Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1 Gastrointestinal 1 CNS 1

Conditions

Interventions

Cisplatin 7 Pemetrexed 6 atezolizumab 5 Carboplatin 4 tislelizumab 3 Paclitaxel 3 Leucovorin 3 Filgrastim 3 Etoposide 3 vistusertib 2 pembrolizumab 2 Vincristine 2 Topotecan 2 Temozolomide 2 Tegafur 2 Sorafenib 2 Irinotecan 2 Immunoenzyme Techniques 2 Gemcitabine 2 Docetaxel 2 Cyclophosphamide 2 zirconium-89-trastuzumab 1 vandetanib 1 toripalimab 1 temsirolimus 1 tanespimycin 1 talazoparib 1 soblidotin 1 selinexor 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Tiragolumab × Other solid neoplasm × Clear all

NCT06331598 2024-12-24

IMperator

Hoffmann-La Roche

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡